Media coverage about Physicians Realty Trust (NYSE:DOC) has trended positive recently, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Physicians Realty Trust earned a coverage optimism score of 0.37 on Accern’s scale. Accern also assigned press coverage about the real estate investment trust an impact score of 45.2005632503033 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Physicians Realty Trust (DOC) opened at $15.39 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.59 and a current ratio of 1.59. The firm has a market cap of $2,672.15, a P/E ratio of 66.92, a PEG ratio of 2.29 and a beta of 0.39. Physicians Realty Trust has a 1-year low of $14.83 and a 1-year high of $21.85.

The business also recently declared a quarterly dividend, which was paid on Thursday, January 18th. Investors of record on Wednesday, January 3rd were issued a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 5.98%. The ex-dividend date was Tuesday, January 2nd. Physicians Realty Trust’s payout ratio is presently 400.02%.

Several equities analysts have recently weighed in on DOC shares. Royal Bank of Canada reaffirmed a “buy” rating and set a $21.00 target price on shares of Physicians Realty Trust in a report on Wednesday, November 15th. Zacks Investment Research lowered shares of Physicians Realty Trust from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. SunTrust Banks set a $18.00 target price on shares of Physicians Realty Trust and gave the company a “hold” rating in a report on Monday, January 22nd. Raymond James Financial set a $20.00 target price on shares of Physicians Realty Trust and gave the company a “buy” rating in a report on Thursday, December 7th. Finally, Robert W. Baird reaffirmed an “outperform” rating and set a $19.00 target price (down from $21.00) on shares of Physicians Realty Trust in a report on Friday, January 5th. One research analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the company. Physicians Realty Trust presently has an average rating of “Buy” and a consensus price target of $20.05.

In related news, Director Tommy G. Thompson purchased 2,705 shares of the business’s stock in a transaction that occurred on Thursday, December 14th. The stock was bought at an average price of $18.46 per share, with a total value of $49,934.30. Following the acquisition, the director now owns 49,339 shares in the company, valued at $910,797.94. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.51% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY WARNING: “Physicians Realty Trust (DOC) Receives Daily Media Sentiment Score of 0.37” was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at

About Physicians Realty Trust

Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.

Insider Buying and Selling by Quarter for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with's FREE daily email newsletter.